Profil

Burtea Carmen

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chimie générale, organique et biomédicale

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Chimie générale, organique et biomédicale

ORCID
0000-0002-1117-1935
Main Referenced Co-authors
LAURENT, Sophie  (202)
MULLER, Robert  (187)
Vander elst, Luce  (155)
SAUSSEZ, Sven  (28)
Toubeau, Gérard (27)
Main Referenced Keywords
peptides (43); MRI contrast agents (41); molecular imaging (35); magnetic resonance imaging (25); Alzheimer's disease (21);
Main Referenced Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (142)
UMHAP - Centre de Recherche UMONS-Ambroise Paré (3)
CISMA - Centre Interdisciplinaire de Spectrométrie de Masse (1)
Main Referenced Disciplines
Chemistry (145)
Radiology, nuclear medicine & imaging (131)
Biotechnology (78)
Zoology (71)
Immunology & infectious disease (70)

Publications (total 262)

The most downloaded
80 downloads
Burtea, C., Laurent, S., Colet, J.-M., Vander Elst, L., & Muller, R. (01 January 2003). Development of new glucosylated derivatives of Gd-DTPA for MRI angiography. Investigative Radiology, 38 ((6)), 320-333. doi:10.1097/01.RLI.0000066251.65982.e6 https://hdl.handle.net/20.500.12907/2224

The most cited

150 citations (Scopus®)

Laurent, S., Burtea, C., Thirifays, C., Häfeli, U. O., & Mahmoudi, M. (10 January 2012). The Importance of toxicity assay modifications and 'Cell Vision'. PLoS ONE, 7 (1), 29997. doi:10.1371/journal.pone.0029997 https://hdl.handle.net/20.500.12907/7345

Book chapters or contributions to a collective book as author or co-author

Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (2008). Contrast Agents: magnetic resonance. In Molecular Imaging I (pp. 135-165). Springer. doi:10.1007/978-3-540-72718-7_7

Articles accepted in reviewed journal

Andre, S., Verteneuil, S., Ris, L., Kahvecioglu, Z. C., Nonclercq, D., De winter, J., Vander elst, L., Laurent, S., Muller, R., & Burtea, C. (29 December 2023). Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer’s Disease. Journal of Alzheimer's Disease Reports, 7 (1), 1395-1426. doi:10.3233/adr-230075
Peer Reviewed verified by ORBi

BOUTRY, S., LAURENT, S., & BURTEA, C. (2023). Editorial for: "Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging". Journal of Magnetic Resonance Imaging. doi:10.1002/jmri.29158
Editorial reviewed

Balas, M., Predoi, D., Burtea, C., & Dinischiotu, A. (07 February 2023). New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International Journal of Molecular Sciences, 24 (4), 3307. doi:10.3390/ijms24043307
Peer Reviewed verified by ORBi

Tchéoubi, S. E. R., Akpovi, C. D., Coppée, F., Decleves, A.-E., Laurent, S., Agbangla, C., & Burtea, C. (November 2022). Molecular and cellular biology of PCSK9: impact on glucose homeostasis. Journal of Drug Targeting, 30 (9), 948 - 960. doi:10.1080/1061186X.2022.2092622
Peer Reviewed verified by ORBi

Boutry, S., Laurent, S., & Burtea, C. (2022). Editorial for "New Cluster Analysis Method for Quantitative DCE-MRI Assessing Tumor Heterogeneity Induced by E7130 Treatment to a Breast Cancer Mouse Model". Journal of Magnetic Resonance Imaging. doi:10.1002/jmri.28225
Editorial reviewed

Crombez, D., Delcambre, S., Nonclercq, D., Vander Elst, L., Laurent, S., Cnop, M., Muller, R., & Burtea, C. (15 August 2020). Modulation of Adiponectin Receptors AdipoR1 and AdipoR2 by Phage Display-Derived Peptides in in vitro and in vivo Models. Journal of Drug Targeting, 28 (7-8), 831-851. doi:10.1080/1061186X.2019.1710840
Peer Reviewed verified by ORBi

Popescu Din, I. M., Balas, M., Hermenean, A., Vander Elst, L., Laurent, S., Burtea, C., Cinteza, L. O., & Dinischiotu, A. (2020). Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement. Materials.
Peer reviewed

Andre, S., Larbanoix, L., Verteneuil, S., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (05 June 2020). Development of an LDL receptor-targeted peptide susceptible to facilitate the brain access of diagnostic or therapeutic agents. Biology, 9, 161, 1-26. doi:10.3390/biology9070161
Peer reviewed

Canei, J., Burtea, C., & Nonclercq, D. (17 April 2020). Comparative study of the visual system of two psammophilic lizards (Scincus scincus & Eumeces schneideri). Vision Research, 171, 17-30.
Peer Reviewed verified by ORBi

Fanfone, D., Stanicki, D., Nonclercq, D., Port, M., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (14 March 2020). Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes. Biology, 9 (53), 1-25. doi:10.3390/biology9030053
Peer reviewed

Demine, S., Balhuizen, A., Debaille, V., Joosten, L., Fereau, M., Chilla, S. N. M., Millard, I., Scharfmann, R., Egrise, D., Goldman, S., Marchetti, P., Gotthardt, M., Laurent, S., Burtea, C., & Eizirik, D. (21 August 2018). Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2 gamma-a. Molecules, 23 (9), 2100. doi:10.3390/molecules23092100
Peer reviewed

Andre, S., Ansciaux, E., Saidi, E., Larbanoix, L., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (07 November 2017). Validation by magnetic resonance imaging of the diagnostic potential of a heptapeptide-functionalized imaging probe targeted to amyloid beta and able to cross the blood-brain barrier. Journal of Alzheimer's Disease, 60 (4), 1547-1565. doi:10.3233/JAD-170563
Peer Reviewed verified by ORBi

Fanfone, D., Despretz, N., Stanicki, D., Rubio Magnieto, J., Fossepre, M., Surin, M., Rorive, S., Salmon, I., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (2017). Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1. Medical Oncology.
Peer Reviewed verified by ORBi

Balas, M., Ciobanu, C. S., Burtea, C., Stan, M. S., Bezirtzoglou, E., Predoi, D., & Dinischiotu, A. (21 February 2017). Characterization, and Toxicity Evaluation of Dextran - Coated Iron Oxide Nanoparticles. Metals, 7 (2), 63-80. doi:10.3390/met7020063
Peer reviewed

Burtea, C., Laurent, S., Sanli, T., Fanfone, D., Devalckeneer, A., Sauvage, S., Beckers, M.-C., Rorive, S., Salmon, I., Vander Elst, L., Lauwerys, B. R., & Muller, R. (10 November 2016). Screening for peptides targeted ti IL-7Ralpha for molecular imaging of rheumatoid arthritis synovium. Arthritis Research and Therapy, 18 (230). doi:10.1186/s13075-016-1133-8
Peer Reviewed verified by ORBi

Dentamaro, M., Lux, F., Vander Elst, L., Dauguet, N., Montante, S., Moussaron, A., Burtea, C., Muller, R., Tillement, O., & Laurent, S. (09 June 2016). Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging. Contrast Media and Molecular Imaging, 11, 381-395. doi:10.1002/cmmi.1702
Peer Reviewed verified by ORBi

Rossez, Y., Burtea, C., Laurent, S., Gosset, P., Renaud, L., Gonzalez, W., Ballet, S., Raynal, I., Rousseaux, O., Dugué, T., Vander Elst, L., Michalski, J.-C., Muller, R., & Robbe-Masselot, C. (14 January 2016). Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC. Contrast Media and Molecular Imaging, 11 (3), 211-221. doi:10.1002/cmmi.1682
Peer Reviewed verified by ORBi

Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging, 10 (3), 211-224. doi:10.1002/CMMI.1626
Peer Reviewed verified by ORBi

Ansciaux, E., Burtea, C., Laurent, S., Nonclercq, D., Vander Elst, L., & Muller, R. (2015). In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging.
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Crombez, D., Delcambre, S., Sermeus, C., Millard, I., Rorive, S., Flamez, D., Beckers, M.-C., Salmon, I., Vander Elst, L., Eizirik, D., & Muller, R. (18 February 2015). Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)gamma-a as a highly specific biomarker of pancreatic beta cells. Contrast Media and Molecular Imaging, 10 (5), 398-412. doi:10.1002/cmmi.1641
Peer Reviewed verified by ORBi

Zghikh, L., Vangysel, E., Nonclercq, D., Legrand, A., Blairon, B., Berri, C., Bordeau, T., Rémy, C., Burtea, C., Montuelle, S., & Bels, V. (02 September 2014). Morphology and fiber-type distribution in the tongue of the Pogona vitticeps lizard (Iguania: Agamidae). Journal of Anatomy, 225 (4), 377-389.
Peer Reviewed verified by ORBi

Mao, H., Chen, W., Laurent, S., Thirifays, C., Burtea, C., Rezaee, F., & Mahmoudi, M. (24 July 2013). Hard Corona Composition and Cellular Toxicities of the Graphene Sheets. Colloids and Surfaces B: Biointerfaces, 109, 212-218.
Peer Reviewed verified by ORBi

Laurent, S., Ng, E.-P., Thirifays, C., Lakiss, L., Goupil, J., Mintova, S., Burtea, C., Oveisi, E., Hebert, C., Vries, M., Motazacker, M., Rezaee, F., & Mahmoudi, M. (25 April 2013). Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions. Toxicology Research, 2, 270-279.
Peer reviewed

Laurent, S., Burtea, C., Thirifays, C., Rezaee, F., & Mahmoudi, M. (15 February 2013). Significance of cell ''observer' and protein source in nanobiosciences. Journal of Colloid and Interface Science, 392, 431.
Peer Reviewed verified by ORBi

Sclavons, C., Burtea, C., Boutry, S., Laurent, S., Vander Elst, L., & Muller, R. (04 February 2013). Phage display screening for tumor necrosis factor-alpha-binding peptides. Detection of inflammation in a mouse model of hepatitis. International Journal of Peptides, 2013, 9. doi:10.1155/2013/348409
Peer Reviewed verified by ORBi

Laurent, S., Ng, E., Thirifays, C., Lakiss, L., Goupil, J., Mintova, S., Burtea, C., Oveisi, E., Hebert, C., Vries, M., Motazacker, M., Rezaee, F., & Mahmoudi, M. (2013). Corona protein composition and cytotoxicity evaluation of ultrasmall zeolites synthesized from template free precursor suspensions. Toxicology Research.
Peer reviewed

Mahmoudi, M., Saeedi-Eslami, S.-E., Shokrgozar, M. A., Azadmanesh, K., Hasanloo, M., Kalhor, H., Burtea, C., Rothen-Rutishauser, B., Laurent, S., Sheibani, S., & Vali, H. (03 December 2012). Cell 'vision': complementary factor of protein corona in nanotoxicology. Nanoscale, 4 (17), 5461-5468.
Peer Reviewed verified by ORBi

Verwilst, P., Eliseeva, S., Vander Elst, L., Burtea, C., Laurent, S., Petoud, S., Muller, R., Parac-Vogt, T. N., & De Borggraeve, W. M. (04 June 2012). A Tripodal Ruthenium-Gadolinium Metallostar as a Potential a(v)ß(3) Integrin Specific Bimodal Imaging Contrast Agent. Inorganic Chemistry, 51 (11), 6405-6411. doi:10.1021/ic300717m
Peer Reviewed verified by ORBi

Burtea, C., Ballet, S., Laurent, S., Rousseaux, O., Dencausse, A., Gonzalez, W., Port, M., Corot, C., Vander Elst, L., & Muller, R. (19 April 2012). Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis targeted ultrasmall superparamagnetic iron oxide derivatives. Arteriosclerosis, Thrombosis, and Vascular Biology, 32 (6), 36-48.
Peer reviewed

Arsalani, N., Fattahi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (04 February 2012). Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging. Contrast Media and Molecular Imaging, 7, 185-194.
Peer Reviewed verified by ORBi

Laurent, S., Burtea, C., Thirifays, C., Häfeli, U. O., & Mahmoudi, M. (10 January 2012). The Importance of toxicity assay modifications and 'Cell Vision'. PLoS ONE, 7 (1), 29997. doi:10.1371/journal.pone.0029997
Peer reviewed

Burtea, C., Laurent, S., Mahieu, I., Larbanoix, L., Roch, A., Port, M., Rousseaux, O., Ballet, S., Murariu, O., Toubeau, G., Corot, C., Vander Elst, L., & Muller, R. (01 July 2011). In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media and Molecular Imaging, 6, 236-250. doi:10.1002/cmmi.423
Peer Reviewed verified by ORBi

Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 July 2011). Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents. Contrast Media and Molecular Imaging, 6 (4), 229-235. doi:10.1002/cmmi.422
Peer Reviewed verified by ORBi

Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (01 June 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32 (6), 1232-43. doi:10.1016/j.peptides.2011.04.026
Peer Reviewed verified by ORBi

Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (06 May 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease. Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32(6), 1232-1243. doi:10.1016/j.peptides.2011.04.026
Peer Reviewed verified by ORBi

Kiyofuji, K., Tsunekawa, K., Yamashita, M., Yamashita, J., Fujie, M., Asai, K., Suyama, T., Ito, S., Reddy, V. K., Yamada, M., Ogawa, K., Ozaki, N., Sugiyama, M., Yamaoka, M., Makita, R., Nakamura, S., Aoki, T., Yu, G., Aoshima, K., ... Muller, R. (01 January 2011). Preparation and Evaluation of Novel Sugar Dendritic Gd-DTPA Complexes for MRI Contrast Agents and Phospha Sugars for Anti-tumour Agents. Advanced Materials Research, 222, 217-220. doi:10.4028/www.scientific.net/AMR.222.217
Peer reviewed

VERWILST, P., ELISEEVA, S. V., CARRON, S., Vander Elst, L., Burtea, C., Dehaen, G., Laurent, S., Binnemans, K., Muller, R., Parac-Vogt, T. N., & De Borggraeve, W. M. (2011). A modular approach towards the synthesis of target-specific MRI contras agents. European Journal of Inorganic Chemistry, 3577-3585. doi:10.1002/ejic.201100575
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Mahieu, I., Larbanoix, L., Roch, A., Port, M., Rousseaux, O., Ballet, S., Murariu, O., Toubeau, G., Corot, C., Vander Elst, L., & Muller, R. (29 December 2010). In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media and Molecular Imaging, 6 (4), 236-50. doi:10.1002/cmmi.423
Peer Reviewed verified by ORBi

Larbanoix, L., Burtea, C., Laurent, S., Van Leuven, F., Toubeau, G., Vander Elst, L., & Muller, R. (31 October 2010). Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease. Neurobiology of Aging, 31 (10), 1679-89. doi:10.1016/j.neurobiolaging.2008.09.021
Peer Reviewed verified by ORBi

Rerat, V., Laurent, S., Burtea, C., Driesschaert, B., Pourcelle, V., Vander Elst, L., Muller, R., & Marchand-Brynaert, J. (15 March 2010). Ultrasmall particle of iron oxide - RGD peptidomimetic conjugate: synthesis and characterization. Bioorganic and Medicinal Chemistry Letters, 20 (6), 1861-1865. doi:10.1016/j.bmcl.2010.01.150
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Rousseaux, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (2009). Molecular MRI of VCAM-1 expression in inflammatory lesions by using a peptide-vectorized paramagnetic imaging probe. Journal of Medicinal Chemistry.
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Lancelot, E., Ballet, S., Murariu, O., Rousseaux, O., Port, M., Vander Elst, L., Corot, C., & Muller, R. (01 January 2009). Peptidic Targeting of Phosphatidylserine for the MRI Detection of Apoptosis in Atherosclerotic Plaques. Molecular Pharmaceutics, 6 (6), 1903-1919. doi:10.1021/mp900106m
Peer Reviewed verified by ORBi

Boutry, S., Forge, D., Burtea, C., Mahieu, I., Murariu, O., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2009). How to quantify iron in an aqueous or biological matrix: a technical note. Contrast Media and Molecular Imaging, 4 (6), 299-203. doi:10.1002/cmmi.291
Peer Reviewed verified by ORBi

Yamashita, J., Yamashita, M., Fujie, M., Suyama, K. A. T., Ito, S., Reddy, V. K., Yamada, M., Ogawa, K., Ozaki, N., Nakamura, S., Aoki, T., Yu, G., Aoshima, K., Kato, T., Kamikage, N., Kiyofuji, K., Takehara, Y., Sakahara, H., Takayanagi, H., ... Muller, R. (01 January 2009). R&D of novel medicinal materials for curing cancer: sugar modified Gd-DTPA MRI contrast agents and Phospha Sugar Anti-cancer agents. Journal of Automation, Mobile Robotics and Intelligent Systems, 3 (4), 80-83.
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Lancelot, E., Ballet, S., Muriariu, O., Rousseaux, O., Port, M., Vander Elst, L., Corot, C., & Muller, R. (2009). Identification of Peptide Ligands that Target Apoptotic Cells by Means of Specific Interactions with Phosphatidylserine. Applications to Molecular Imaging by MRI. Molecular Pharmaceutics.
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Rousseaux, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (01 January 2009). Magnetic Resonance Molecular Imaging of Vascular Cell Adhesion Molecule-1 Expression in Inflammatory Lesions Using a Peptide-Vectorized Paramagnetic Imaging Probe. Journal of Medicinal Chemistry, 52 (15), 4725-4742. doi:10.1093/cvr/cvm115
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Murariu, O., Rattat, D., Toubeau, G., Verbruggen, A., Vansthertem, D., Vander Elst, L., & Muller, R. (01 January 2008). Molecular imaging of alpha(v)beta(3) integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovascular Research, 78 (1), 148-157. doi:10.1093/cvr/cvm115
Peer Reviewed verified by ORBi

Yu, G., Yamashita, M., Aoshima, K., Takahashi, M., Oshikawa, T., Takayanagi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (2007). A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography ? Bioorganic and Medicinal Chemistry Letters.
Peer Reviewed verified by ORBi

Yu, G., Yamashita, M., Aoshima, K., Takahashi, M., Oshikawa, T., Takayanagi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 January 2007). A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography? Bioorganic and Medicinal Chemistry Letters, 17 (8), 2246-2249. doi:10.1016/j.bmcl.2007.01.067
Peer Reviewed verified by ORBi

Yu, G., Yamashita, M., Aoshima, K., Kobayashi, M., Kato, T., Kamikage, N., Takahashi, M., Takayanagi, H., Oshikawa, T., Laurent, S., Burtea, C., Vander Elst, L., Muller, R., Takehara, Y., & Sakahara, H. (01 January 2007). Studies on preparation and characterization of novel MRI contrast agents for targeting organs and blood vessels. Heterocyclic Communications, 13 (2-3), 101-108.
Peer Reviewed verified by ORBi

Segers, J., Laumonier, C., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2007). From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. Bioconjugate Chemistry, 18 (4), 1251-1258. doi:10.1021/bc060377f
Peer Reviewed verified by ORBi

Parac-Vogt, T. N., Vander Elst, L., Kimpe, K., Laurent, S., Burtea, C., Chen, F., Vand Deun, R., Ni, Y. C., Muller, R., & Binnemans, K. (01 January 2006). Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity. Contrast Media and Molecular Imaging, 1 (6), 267-278. doi:10.1002/cmmi.114
Peer Reviewed verified by ORBi

Parac-Vogt, T. N., Kimpe, K., Laurent, S., Vander Elst, L., Burtea, C., Chen, F., Muller, R., Ni, Y. C., Verbruggen, A., & Binnemans, K. (01 January 2005). Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity. Chemistry, 11 (10), 3077-3086. doi:10.1002/chem.200401207
Peer Reviewed verified by ORBi

Boutry, S., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (01 January 2005). Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magnetic Resonance in Medicine, 53 (4), 800-807. doi:10.1002/mrm.20403
Peer Reviewed verified by ORBi

Boutry, S., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (2005). Magnetic Resonance Imaging of Inflammation With a Specific Selectin-Targeted Contrast Agent. Magnetic Resonance in Medicine.
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Roch, A., Vander Elst, L., & Muller, R. (01 January 2005). C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI. Journal of Inorganic Biochemistry, 99 (5), 1135-1144. doi:10.1016/j.jinorgbio.2005.02.009
Peer Reviewed verified by ORBi

Gossuin, Y., Burtea, C., Monseux, A., Toubeau, G., Roch, A., Muller, R., & Gillis, P. (11 May 2004). Ferritin-induced relaxation in tissues: An in vitro study. Journal of Magnetic Resonance Imaging, 20 (4), 690-697. doi:10.1002/jmri.20152
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Colet, J.-M., Vander Elst, L., & Muller, R. (01 January 2003). Development of new glucosylated derivatives of Gd-DTPA for MRI angiography. Investigative Radiology, 38 ((6)), 320-333. doi:10.1097/01.RLI.0000066251.65982.e6
Peer Reviewed verified by ORBi

Dumitru, I., Burtea, C., Balta, N., Stoian, G., Mekhalfia, A., & Petec, G. (19 November 1998). An assay on blood, heart and liver biochemical markers in myocardial hypertrophy induced by isoproterenol. Romanian Biotechnological Letters, 3 (3), 221-236.
Peer Reviewed verified by ORBi

Burtea, C., Gatina, R., Stoian, G., Mardare, M., Dumitru, I., & Dragomir, C. (03 November 1998). Spin-spin relaxation times in myocardial hypertrophy induced by endocrine agents in rat. Magnetic Resonance Materials in Biology, Physics and Medicine, 7, 184-198. doi:10.1007/BF02591336
Peer Reviewed verified by ORBi

Burtea, C., Stoian, G., Mekhalfia, A., Balta, N., & Dumitru, I. (15 October 1998). Metabolic alterations in rat myocardium and liver after treatment with high doses of ACTH and isoproterenol. Journal of Medicine and Biochemistry, 3 (1), 35-51.
Peer reviewed

Gatina, R., Balta, N., Moisin, C., Burtea, C., Botea, S., Ioan, M., & Teleianu, C. (10 July 1998). Research on red cell membrane permeability in arterial hypertension. Romanian Journal of Physiology: Physiological Sciences, 35 (3-4), 285-302.
Peer Reviewed verified by ORBi

Dumitru, I., Burtea, C., Stoian, G., Mardare, M., Mekhalfia, A., & Balta, N. (15 June 1998). Tissue water alterations in rat liver and myocardium exposed to ACTH and isoproterenol treatment. A relaxometric study. Journal of Medicine and Biochemistry, 2 (3), 237-249.
Peer reviewed

Miscalencu, D., Dumitru, I., Mailat, F., Burtea, C., Ivanciuc, L., & Barbu, E. (11 June 1998). Ultrastructural changes induced by isoproterenol and ACTH in hepatocytes and heart myocytes. Journal of Medicine and Biochemistry, 2 (4), 353-359.
Peer reviewed

Dumitru, I., Burtea, C., Stoian, G., Mardare, M., Mekhalfia, A., & Balta, N. (1998). Modulation of the enzymes involved in rat liver glutathione metabolism by high doses of ACTH and isoproterenol. Journal of Medicine and Biochemistry.
Peer reviewed

Balta, N., Stoian, G., Boca, A., Burtea, C., Petec, G., Moisin, C., Teleianu, C., & Dumitru, I. (17 November 1997). Biochemical and histo-enzymological investigations of the myocardium and coronary system in assessing experimental cardiac hypertrophy. Journal of Medicine and Biochemistry, 1 (3), 161-182.
Peer reviewed

Burtea, C., Mihalache, D., & Ungureanu, B. (20 May 1997). Precocious signals detected by 1H-NMR in rat liver exposed to oncogenic stress, interfering with fat-soluble vitamins D3 and E. Libri Oncologici: Croatian Journal of Oncology, 26 (1), 19-24.
Peer reviewed

Burtea, C., Balta, N., Stoian, G., Petec, G., & Dumitru, I. (12 April 1997). A 1H-NMR study on the modulator effect of retinoic acid in the alcoholic intoxication. The identification of tissue water injuries induced by ethanol on liver and myocardium. Journal of Medicine and Biochemistry, 1 (1), 25-36.
Peer reviewed

Dumitru, I., Balta, N., Burtea, C., Stoian, G., & Petec, G. (16 May 1996). The protective role of thiamine associated with medicinal products based on biogenic amines and the metabolic modifications made evident by 1H-NMR. Romanian Biotechnological Letters, 1 (3), 171-180.
Peer Reviewed verified by ORBi

Burtea, C., Gatina, R., Dinischiotu, A., Mocanu, M., & Nastasescu, G. (17 November 1995). Studies on the steroid hormones involvement in the muscular fatigue phenomena. Studii şi Cercetări de Biochimie, 38 (1-2), 11-18.
Peer reviewed

Burtea, C., Gatina, R., Vasilescu, A., & Nastasescu, G. (11 November 1995). NMR and radioizotope studies concerning the steroid hormones influence over the contractile proteins of skeletal muscle. Studii şi Cercetări de Biochimie, 38 (1-2), 3-10.
Peer reviewed

Burtea, C., Gatina, R., Mocanu, M., Dinischiotu, A., & Nastasescu, G. (07 April 1995). Catecholamines and Ca2+ involvement in potentiating the resistance to physical effort induced by anabolic steroids. Sex-related differences. Romanian Journal of Endocrinology, 33 (1-4), 31-39.
Peer Reviewed verified by ORBi

Botea, S., Burtea, C., & Mocanu, M. (07 April 1995). The influence of oestradiol treatment upon the protection conferred by preconditioning in ischaemic rat myocardium in vitro. Romanian Journal of Endocrinology, 33 (3-4), 49-55.
Peer Reviewed verified by ORBi

Burtea, C., Gatina, R., Lefter, C., David, A., Nastasescu, G., & Butnaru, F. (15 October 1993). The role of cathecolamines in muscle growth. Romanian Journal of Endocrinology, 31 (3-4), 115-122.
Peer Reviewed verified by ORBi

Burtea, C., David, A., & Butnaru, F. (10 April 1993). The role of catecholamines in the distribution of steroid hormones in the striated and cardiac muscle. Romanian Journal of Endocrinology, 31 (1-2), 41-48.
Peer Reviewed verified by ORBi

Burtea, C., Lefter, C., Butnaru, F., & David, A. (20 October 1992). Steroid hormones control on nucleic acid biosynthesis in skeletal muscle. Romanian Journal of Endocrinology, 30 (3-4), 109-114.
Peer Reviewed verified by ORBi

Burtea, C., Murgiuc, C., David, A., & Dragomir, C. (25 September 1992). Influence of sex and glucocorticoid hormones on 3H-cholesterol uptake in the aortic wall and 3H-adrenaline in the brain. Romanian Journal of Endocrinology, 29 (3-4), 137-145.
Peer Reviewed verified by ORBi

Book reviews

Dumitru, I., Balta, N., Burtea, C., Stoian, G., Mekhalfia, A., & Petec, G. (19 November 1997). Cardioprotective effect of fosfobion and thiamin in isoproterenol-induced myocardial hypertrophy. Journal of Medicine and Biochemistry, 1 (4), 273-290.

Oral presentations in conferences with scientific selection committee

Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Paper presentation]. Physphar Spring meeting (2023), Brussels, Belgium.
Editorial reviewed

TCHEOUBI, S. E. R.* , AKPOVI, C. D., Coppée, F., Decleves, A.-E., FIOGBE, S. E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C. (06 September 2021). PCSK9 intronic variant rs142149050 is associated with low level of LDL-cholesterol and lower cardiovascular risk in type 2 diabetes [Paper presentation]. - 4ème Congrès international de la Société Africaine de Physiologie et Physiopathologie (SA2P), Cotonou, Benin.
Peer reviewed

Derenne, A., Tassin, A., Burtea, C., Decleves, A.-E., & Coppée, F. (13 September 2017). Development of specific molecules using the phage display technology allowing a targeted drug delivery to skeletal muscles in the aim to treat muscular disorders.» [Paper presentation]. Journée PhD day EDT en Sciences Pharmaceutiques, Liège, Belgium.
Editorial reviewed

Patents

Burtea, C., Laurent, S., & ANDRE, S. (17 June 2021). PEPTIDES BINDING TO LDL-RECEPTOR AS CARRIERS FOR CROSSING THE BLOOD BRAIN BARRIER.

Burtea, C., Andre, S., & Laurent, S. (10 December 2019). Peptides binding to LDL receptor as carriers for crossing the blood-brain barrier.

Burtea, C., Crombez, D., & Laurent, S. (24 December 2018). PEPTIDE AGONISTS OF ADIPONECTIN RECEPTORS 1 AND 2.

Burtea, C., Laurent, S., Muller, R., Stanicki, D., Fanfone, D., & Saussez, S. (26 September 2017). Galectin-1 binding peptides and use thereof for diagnostic and therapeutic purpose.

Muller, R., Eizirik, D., Sermeus, C., Laurent, S., Burtea, C., Beckers, M.-C., & Flamez, D. (27 December 2012). Molecules specifically binding pancreatic beta cells biomarkers.

Burtea, C., Laurent, S., Muller, R., Sermeus, C., & Eizirik, D. (26 December 2012). Molecules specifically binding pancreatic beta cells biomarkers.

Burtea, C., Laurent, S., Muller, R., Sermeus, C., & Eizirik, D. (23 June 2011). Molecules specifically binding pancreatic beta cells biomarkers.

Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for the diagnosis of diseases associated with VCAM expression.

Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for diagnosing apoptosis.

Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for diagnosing apoptosis.

Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). Compounds for the diagnosis of diseases associated with VCAM expression.

Contact ORBi UMONS